Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19

NCT04368377 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Pneumonia, Viral
Corona Virus Infection
Respiratory Failure
Embolism and Thrombosis

Interventions

DRUG: Tirofiban Injection
DRUG: Clopidogrel
DRUG: Acetylsalicylic acid
DRUG: Fondaparinux

Sponsor

University of Milan

Collaborators

[object Object]